Meng et al. showed that the efficacy of docetaxel, used in the treatment of gastric cancer, was significantly increased when used in combination with siRNA-mediated STMN1 silencing in both in vivo and in vitro (Meng et al., 2016). The gene discussed is STMN1; the disease is gastric cancer.